Charles River banner on Wall Street
Media Coverage

Why Charles River Labs is the Biotech stock to buy: Jim Cramer


Jim Cramer said that Charles River Labs (CRL - Get Report) is the "arms merchant of biotech." "The biotech companies themselves do not have enough money to develop drugs. So you have to send to Charles River Labs, which by the way, if you want to get a hold of them, you dial 1-800-LAB-RAT," Cramer advised.

"If we have this big IPO rush...stocks tend to get sold on an IPO rush. But, I do think the Charles River Labs is a great way to play this whole revolution," Cramer said.

Watch the video